Pages that link to "Q60314995"

The following pages link to Brian F Thomas (Q60314995):

Displaying 28 items.

• Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor. (Q30558573) (← links)
• Synthesis and biological evaluation of bivalent ligands for the cannabinoid 1 receptor. (Q33693780) (← links)
• Toward the Development of Bivalent Ligand Probes of Cannabinoid CB1 and Orexin OX1 Receptor Heterodimers (Q33768567) (← links)
• Diarylureas as allosteric modulators of the cannabinoid CB1 receptor: structure-activity relationship studies on 1-(4-chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1). (Q34243225) (← links)
• Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: implications for nontargeted screening of designer drugs (Q34314602) (← links)
• Synthesis, pharmacology, and molecular modeling of novel 4-alkyloxy indole derivatives related to cannabimimetic aminoalkyl indoles (AAIs). (Q34440766) (← links)
• Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents (Q34453709) (← links)
• Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs (Q34520933) (← links)
• Diaryl urea analogues of SB-334867 as orexin-1 receptor antagonists (Q34899602) (← links)
• Current evidence supporting a role of cannabinoid CB1 receptor (CB1R) antagonists as potential pharmacotherapies for drug abuse disorders. (Q36251616) (← links)
• Use of SPME-HS-GC-MS for the analysis of herbal products containing synthetic cannabinoids. (Q36727502) (← links)
• Identification of [14C]fluasterone metabolites in urine and feces collected from dogs after subcutaneous and oral administration of [14C]fluasterone. (Q37195536) (← links)
• Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles (Q37397048) (← links)
• Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders (Q37444808) (← links)
• Truncated Orexin Peptides: Structure-Activity Relationship Studies (Q37683433) (← links)
• Novel, potent THC/anandamide (hybrid) analogs. (Q40083173) (← links)
• The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes. (Q40987563) (← links)
• The importance of hydrogen bonding and aromatic stacking to the affinity and efficacy of cannabinoid receptor CB2 antagonist, 5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-pyrazole-3- (Q42940086) (← links)
• Pharmacokinetic and tissue distribution study of [14C]fluasterone in male Beagle dogs following intravenous, oral and subcutaneous dosing routes. (Q43259876) (← links)
• Assessment of structural commonality between tetrahydrocannabinol and anandamide (Q43854025) (← links)
• Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols (Q44356912) (← links)
• Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. (Q48573434) (← links)
• Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore. (Q54467581) (← links)
• Determination of ibogaine in plasma by gas chromatography--chemical ionization mass spectrometry (Q71564464) (← links)
• Determination of l-alpha-acetylmethadol, l-alpha-noracetylmethadol and l-alpha-dinoracetylmethadol in plasma by gas chromatography-mass spectrometry (Q72177121) (← links)
• QSAR analysis of Delta(8)-THC analogues: relationship of side-chain conformation to cannabinoid receptor affinity and pharmacological potency (Q73348877) (← links)
• Indenopyride derivative RTI-4587-073(l): a candidate for male contraception in stallions (Q87349494) (← links)
• Acute and chronic effects of a contraceptive compound RTI-4587-073(l) on testicular histology and endocrine function in miniature horse stallions (Q95561905) (← links)